Anuh Pharma's Stock Reaches All-Time High, Outperforms Sector by 9.55%
Anuh Pharma, a smallcap pharmaceutical company, has been gaining attention in the industry with its recent performance. Its stock reached an all-time high on February 19, 2024, and is currently a 'Strong Buy' according to MarketsMojo. The stock has consistently outperformed the sector and is trading higher than its moving averages. Anuh Pharma's impressive performance of 160.25% in the past year solidifies its position as a strong player in the industry. The company's focus on quality and innovation, along with multiple regulatory approvals, has contributed to its success. With its potential for growth, Anuh Pharma is a company to watch out for in the smallcap pharmaceutical industry.
Anuh Pharma, a smallcap pharmaceutical company, has been making waves in the industry with its recent performance. On February 19, 2024, the company's stock price reached an all-time high, signaling a positive trend for the company.
According to MarketsMOJO, a leading stock market analysis and recommendation platform, Anuh Pharma's stock is a 'Strong Buy'. This is a testament to the company's strong performance and potential for growth.
In today's trading session, Anuh Pharma's stock outperformed the sector by 9.55%, opening with a gain of 5.52%. The stock also touched an intraday high of Rs 238.8, a significant increase of 15.59%.
Anuh Pharma's stock is also trading higher than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages, indicating a consistent upward trend.
In the past year, Anuh Pharma has shown an impressive performance of 160.25%, outperforming the Sensex's performance of 18.79%. This further solidifies the company's position as a strong player in the pharmaceutical industry.
Anuh Pharma's success can be attributed to its focus on quality and innovation in its products. The company has been consistently expanding its product portfolio and has received several approvals from regulatory bodies.
With its strong performance and potential for growth, Anuh Pharma is definitely a company to watch out for in the smallcap pharmaceutical industry. Investors can consider adding this stock to their portfolio for long-term gains.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
